Dechra® DermaBenSS® Shampoo (12 fl oz / 355ml)

Designed for use on oily and scaly skin (seborrhea oleosa),
superficial and deep pyodermas, crusty pyodermas, and can also be used as adjunctive therapy for generalized demodicosis and Schnauzer comedo syndrome or other causes of folliculitis.

Benzoyl peroxide may bleach fabrics and other absorbent
materials. Use carefully (gloves are recommended), and avoid contact with clothing and furnishings.

Active Ingredients
• 2.5% Benzoyl Peroxide provides antimicrobial (especially
antibacterial), keratolytic, comedolytic (follicular flushing),
and degreasing actions.
• 1% Salicylic Acid provides mild antipruritic, antibacterial,
keratoplastic, and keratolytic actions; lowers the skin pH and increases corneocyte hydration. Salicylic acid and sulfur have shown to be synergistic in their keratolytic actions.
• Comprehensive skin lipid complex includes Ceramide 3,
Ceramide 6 II, Ceramide 1, phytosphingosine and cholesterol. Ceramides aid in moisturizing, repairing, and restoring dry, damaged skin.

Shake well before use.
Apply to wet coat, rub onto skin, hair and coat to create a rich lather.
Allow shampoo to remain on skin and coat for 5-10 minutes.
Rinse well.
Can be used daily or as indicated by your veterinarian.

Caution: For tropical use only. Avoid contact with eyes. If skin irritation develops or increases, stop use and call your veterinarian. Keep out of reach of children and pets.

Human warning:
Wash hands after use. Rare but serious allergic reactions have been reported with exposure to chlorhexidine gluconate.

Dechra is a global specialist in veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.

We are a global leader in veterinary endocrinology and topical dermatology, have a broad portfolio of analgesia, anaesthetics and products for the treatment of pain, and we are also recognised as innovators in other specialisations such as the treatment of equine lameness, nutrition and differentiated generics.

Headquarted in Norwich, England and is listed on the London Stock Exchange.